Please wait

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Name of Issuer)

(Title of Class of Securities)

(CUSIP Number)

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

X0202 SCHEDULE 13D/A 0001857685 XXXXXXXX LIVE 5 Class A Common Stock, par value $0.0001 per share 05/07/2026 false 0001818093 88331L108 SkinHealth Systems Inc. 3600 E. Burnett Street Long Beach CA 90815 Brian Miller (312) 506-5600 c/o Linden Capital Partners 110 N. Wacker Dr., 55th Floor Chicago IL 60606 0001860184 N LCP Edge Holdco, LLC b OO N DE 0 33360741 0 33360741 33360741 N 25.74 OO Calculated based on 129,600,040 shares of Class A Common Stock, par value $0.0001 per share ("Class A Shares"), outstanding as of May 5, 2026, as reported on the Issuer's Form 10-Q, filed with the Securities and Exchange Commission ("SEC") on May 7, 2026 (the "Form 10-Q"). 0001859894 N Linden Capital III LLC b OO N DE 0 33360741 0 33360741 33360741 N 25.74 OO Calculated based on 129,600,040 shares of Class A Shares outstanding as of May 5, 2026, as reported on the Issuer's Form 10-Q. 0001859892 N Linden Manager III LP b OO N DE 0 33360741 0 33360741 33360741 N 25.74 PN Calculated based on 129,600,040 shares of Class A Shares outstanding as of May 5, 2026, as reported on the Issuer's Form 10-Q. 0001627844 N Linden Capital Partners III LP b OO N DE 0 33360741 0 33360741 33360741 N 25.74 PN Calculated based on 129,600,040 shares of Class A Shares outstanding as of May 5, 2026, as reported on the Issuer's Form 10-Q. 0001627845 N Linden Capital Partners III-A LP b OO N DE 0 33360741 0 33360741 33360741 N 25.74 PN Calculated based on 129,600,040 shares of Class A Shares outstanding as of May 5, 2026, as reported on the Issuer's Form 10-Q. 0001563784 N Anthony Davis b OO N X1 0 33360741 0 33360741 33360741 N 25.74 IN Calculated based on 129,600,040 shares of Class A Shares outstanding as of May 5, 2026, as reported on the Issuer's Form 10-Q. 0001857685 N Brian Miller b OO N X1 0 33360741 0 33360741 33360741 N 25.74 IN Calculated based on 129,600,040 shares of Class A Shares outstanding as of May 5, 2026, as reported on the Issuer's Form 10-Q. Class A Common Stock, par value $0.0001 per share SkinHealth Systems Inc. 3600 E. Burnett Street Long Beach CA 90815 This Amendment No. 5 to the statement on Schedule 13D amends and supplements the statement on Schedule 13D filed by the Reporting Persons with the SEC on May 14, 2021 (the "Original Schedule 13D") as amended by Amendment No. 1 filed by the Reporting Persons with the SEC on May 21, 2021, Amendment No. 2 filed by the Reporting Persons with the SEC on July 19, 2021, Amendment No. 3 filed by the Reporting Persons with the SEC on July 7, 2023, and Amendment No. 4 filed by the Reporting Persons with the SEC on March 14, 2024 (together with this Amendment No. 5, the "Schedule 13D" or the "Statement"). Except as amended herein, the Original Schedule 13D remains in full force and effect. Terms defined in the Original Schedule 13D are used herein as so defined. Item 5(a) of the Schedule 13D is hereby amended and restated as follows: The information set forth in rows (11) and (13) of the cover pages hereto is incorporated by reference into this Item 5. The Reporting Persons hold an aggregate 33,360,741 shares of Class A Shares, representing approximately 25.74% of the Class A Shares outstanding as of May 5, 2026. All such ownership percentages of the securities reported herein are based upon 129,600,040 shares of Class A Shares outstanding as of May 5, 2026 as reported in the Issuer's Form 10-Q. LCP directly holds the 33,360,741 shares of Class A Shares referred to herein. As a result of the relationships described in Item 2, the 33,360,741 shares of Class A Shares may be deemed to be beneficially owned by each of Linden Capital III, LLC, Linden Manager III, LP, Linden Capital Partners III, LP, Linden Capital Partners III-A, LP, Brian Miller and Anthony Davis. This Amendment No. 5 is being filed to reflect a change in the percentage previously reported solely as a result of the change in the outstanding Class A Shares. There have been no other material changes to the information previously reported since the filing of Amendment No. 4. Neither the filing of this Schedule 13D nor any of its contents shall be deemed to constitute an admission by any of the Reporting Persons that it is the beneficial owner of any of the Class A Shares referred to herein for the purposes of Section 13(d) of the Act, or for any other purpose. Item 5(b) of the Schedule 13D is hereby amended and restated as follows: The information set forth in rows (7) through (10) of the cover pages hereto and in Item 5(a) hereof is incorporated by reference into this Item 5. None of the Reporting Persons has effected any transactions related to the Class A Shares during the past 60 days. LCP Edge Holdco, LLC /s/ Brian Miller Brian Miller / President 05/11/2026 Linden Capital III LLC /s/ Brian Miller Brian Miller / Managing Partner 05/11/2026 Linden Manager III LP /s/ Brian Miller Brian Miller / Managing Partner 05/11/2026 Linden Capital Partners III LP /s/ Brian Miller Brian Miller / Managing Partner 05/11/2026 Linden Capital Partners III-A LP /s/ Brian Miller Brian Miller / Managing Partner 05/11/2026 Anthony Davis /s/ Brian Miller Brian Miller / Attorney-in-Fact 05/11/2026 Brian Miller /s/ Brian Miller Brian Miller 05/11/2026 Linden Manager III LP, By: Linden Capital III LLC Its: General Partner. Linden Capital Partners III LP, By: Linden Manager III LP Its: General Partner, By: Linden Capital III LLC Its: General Partner. Linden Capital Partners III-A LP, By: Linden Manager III LP Its: General Partner, By: Linden Capital III LLC Its: General Partner.